With this development, India is soon to begin the domestic production of anti-viral drug remdesivir which would have efficacy, stability, safety for “restricted emergency use” on Covid-19 patients, official added.
source https://www.hindustantimes.com/india-news/domestic-pharma-giants-cipla-hetero-got-dcgi-s-nod-to-manufacture-sell-anti-viral-remdesivir-drug-to-fight-covid-19/story-d0SO89nj6xi7fLG7C29SWM.html
No comments:
Post a Comment